ImmunityBio (IBRX) has been flagged on the FINRA Reg SHO threshold list for 49 consecutive days, a clear signal of sustained short-selling pressure. The threshold list identifies stocks with high short-volume ratios, and IBRX's prolonged presence suggests that short sellers are maintaining significant activity in the name. Trading at $8.49, the stock is currently under scrutiny by market participants monitoring for potential settlement issues. As a reminder, this data reflects daily short-selling flow rather than total open short interest, but it is a vital indicator of ongoing bearish sentiment in the market.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.